STOCK TITAN
  1. Home
  2. Sec-filings
  3. GKOS
  4. [Form 4] GLAUKOS Corp Insider Trading Activity

Glaukos Corp (GKOS) director Kliman receives new RSU and option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GLAUKOS Corp director Gilbert H. Kliman received new equity awards as part of the company’s director compensation program. He was granted 1,878 shares of common stock in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and will be settled in an equal number of shares.

He also received a stock option for 2,987 shares of common stock with an exercise price of $53.57 per share, vesting in full one year after the grant and expiring on May 28, 2036. After these awards, Kliman directly holds 37,406 shares of common stock. Footnote disclosure states this total includes 4,609 restricted stock units that are either unvested or vested but with delivery deferred.

Positive

  • None.

Negative

  • None.
Insider Kliman Gilbert H
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,987 $0.00 --
Grant/Award Common Stock 1,878 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 2,987 shares (Direct, null); Common Stock — 37,406 shares (Direct, null)
Footnotes (1)
  1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. Includes 4,609 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
RSU grant 1,878 shares Restricted stock units granted May 28, 2026, vest in one year
Option grant size 2,987 shares Stock option covering common stock granted May 28, 2026
Option exercise price $53.57 per share Exercise price for 2,987-share option grant
Option expiration May 28, 2036 Expiration date of newly granted stock option
Shares held after awards 37,406 shares Total direct common stock holdings following transactions
Unvested/deferred RSUs included 4,609 units RSUs unvested or vested with deferred delivery included in total
Award transactions counted as acquisitions 2 transactions Form 4 shows two grant/award acquisitions on May 28, 2026
restricted stock units financial
"Represents a grant of restricted stock units received by the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Director Compensation Policy financial
"received by the Reporting Person pursuant to the Issuer's Director Compensation Policy"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price": "53.5700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
grant, award, or other acquisition regulatory
"transaction_code_description": "Grant, award, or other acquisition""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kliman Gilbert H
(Last)(First)(Middle)
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY
(Street)
ALISO VIEJO CALIFORNIA 92656
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/28/2026A1,878(1)A$037,406(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$53.5705/28/2026A2,98705/28/2027(3)05/28/2036Common Stock2,987$02,987D
Explanation of Responses:
1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock.
2. Includes 4,609 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
3. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
Diana Scherer, Attorney-in-Fact06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Gilbert H. Kliman receive from GLAUKOS Corp (GKOS)?

Gilbert H. Kliman received 1,878 restricted stock units and a stock option covering 2,987 shares of common stock. Both awards were granted under GLAUKOS Corp’s Director Compensation Policy as part of his service on the board.

When do Gilbert H. Kliman’s new GLAUKOS (GKOS) equity awards vest?

Both the 1,878 restricted stock units and the option for 2,987 shares vest in full on the one-year anniversary of the May 28, 2026 grant date. Vesting means Kliman earns the right to receive or exercise those shares.

What is the exercise price and term of Gilbert H. Kliman’s new GLAUKOS stock options?

The newly granted stock option covers 2,987 shares of GLAUKOS common stock at an exercise price of $53.57 per share. The option expires on May 28, 2036, giving Kliman up to 10 years from grant to exercise once vested.

How many GLAUKOS (GKOS) shares does Gilbert H. Kliman hold after these awards?

After the new grants, Gilbert H. Kliman directly holds 37,406 shares of GLAUKOS common stock. Footnotes clarify this figure includes 4,609 restricted stock units that are unvested or vested with delivery deferred to a later date.

Were Gilbert H. Kliman’s recent GLAUKOS (GKOS) transactions open-market buys or sales?

The reported transactions are equity awards, not open-market trades. Kliman received restricted stock units and stock options at no cash cost under the company’s Director Compensation Policy, so there were no market purchases or sales in this filing.